Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choice

Vaishali Sanchorawala, Ashutosh D. Wechalekar, Kihyun Kim, Stefan O. Schönland, Heather J. Landau, Fiona Kwok, Kenshi Suzuki, Angela Dispenzieri, Giampaolo Merlini, Raymond L. Comenzo, Dasha Cherepanov, Vanessa C. Hayden, Arun Kumar, Richard Labotka, Douglas V. Faller, Efstathios Kastritis

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choice'. Together they form a unique fingerprint.

Medicine & Life Sciences